Transcriptomic modification induced by the first cycle of neoadjuvant chemotherapy impacts response to treatment in triple negative breast cancer (TNBC)

被引：0
|
作者：
Desmoulins, Isabelle
Chardin, David
Richard, Corentin
Arnould, Laurent
Cochet, Alexandre
Humbert, Olivier
Boidot, Romain
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 05期
关键词：
D O I：
10.1158/1538-7445.SABCS22-P2-26-23
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2-26-23
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Neoadjuvant Chemotherapy in Triple Negative Breast Cancer: An Observational Study
    Shao, Zhiying
    Chaudhri, Shalini
    Guo, Meng
    Zhang, Longzhen
    Rea, Daniel
    ONCOLOGY RESEARCH, 2016, 23 (06) : 291 - 302
  • [42] Neoadjuvant Versus Adjuvant Chemotherapy for Triple Negative Breast Cancer
    Kennedy, Carlie R.
    Gao, Feng
    Margenthaler, Julie A.
    JOURNAL OF SURGICAL RESEARCH, 2010, 163 (01) : 52 - 57
  • [43] The role of glucocorticoid receptor (GR) expression in predicting pathological complete response (pCR) to neoadjuvant chemotherapy in triple-negative breast cancer (TNBC)
    Saha, P.
    Turk, A.
    Lurain, K.
    Baker, G.
    Conzen, S.
    Nanda, R.
    CANCER RESEARCH, 2016, 76
  • [44] Response to the anti-EGFR antibody panitumumab combined with standard neoadjuvant chemotherapy in triple negative breast cancer (TNBC): the immune and IGFR pathways
    Penault-Ilorca, Frederique
    Abrial, Catherine
    Dauplat, Marie-Melanie
    Privat, Maud
    Uhrhammer, Nancy
    Desrichard, Alexis
    Bidet, Yannick
    Radosevic-Robin, Nina
    Cayre, Anne
    Aube, Cecile
    Kwiatkowski, Fabrice
    Chalabi, Nassera
    Bignon, Yves-Jean
    Chollet, Philippe
    Nabholtz, Jean-Marc
    CANCER RESEARCH, 2013, 73 (08)
  • [45] Molecular dissection of chemotherapy response in triple negative breast cancer (TNBC) using microscaled proteogenomics.
    Anurag, Meenakshi
    Jaehnig, Eric
    Satpathy, Shankha
    Krug, Karsten
    Lei, Jonathan T.
    Dou, Yongchao
    Kim, Beom-Jun
    Sullivan, Cathy M.
    Mani, D. R.
    Bergstrom, Erik J.
    Echeverria, Gloria V.
    Hagemann, Ian S.
    Otte, Kristen
    Rodriguez, Henry
    Robles, Ana I.
    Lewis, Michael T.
    Gillette, Michael
    Zhang, Bing
    Rimawi, Mothaffar F.
    Carr, Steven
    Ademuyiwa, Foluso O.
    Ellis, Matthew J.
    CANCER RESEARCH, 2021, 81 (13)
  • [46] Artificial Intelligence Driven Neoadjuvant Chemotherapy Response Prediction in Triple Negative Breast Cancer (TNBC) Unveils Non-linear Feature Interactions
    Huang, Zhi
    Han, Zhi
    Parwani, Anil
    Huang, Kun
    Li, Zaibo
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1459 - 1461
  • [47] Pretreatment neutrophil to lymphocyte ratio (NLR) in patients with triple negative breast cancer (TNBC) treated with neoadjuvant chemotherapy.
    Walker, Paul R.
    Hildebrand, Jessica R.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [48] Carboplatin-containing neoadjuvant chemotherapy for triple negative breast cancer (TNBC): A propensity score-matched study
    Dieci, M. V.
    Giorgi, C. A.
    Griguolo, G.
    Angelini, S.
    Miglietta, F.
    Giarratano, T.
    Falci, C.
    Faggioni, G.
    Tasca, G.
    Mioranza, E.
    Vernaci, G.
    Menichetti, A.
    Mantiero, M.
    Genovesi, E.
    Frezzini, S.
    Saibene, T.
    Michieletto, S.
    Guarneri, V.
    ANNALS OF ONCOLOGY, 2019, 30 : 64 - +
  • [49] Artificial Intelligence Driven Neoadjuvant Chemotherapy Response Prediction in Triple Negative Breast Cancer (TNBC) Unveils Non-linear Feature Interactions
    Huang, Zhi
    Han, Zhi
    Parwani, Anil
    Huang, Kun
    Li, Zaibo
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1459 - 1461
  • [50] Efficacy of neoadjuvant carboplatin/docetaxel chemotherapy in sporadic and BRCA-associated triple-negative breast cancer (TNBC)
    Sharma, Priyanka
    Stecklein, Shane R.
    Kimler, Bruce F.
    Khan, Qamar J.
    Connor, Carol Sue
    McGinness, Marilee
    Mammen, Joshua
    Wagner, Jamie Lynn
    Jensen, Roy A.
    Godwin, Andrew K.
    Fabian, Carol J.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345